Oncolytic Virus Immunotherapy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Engineering Oncolytic Viruses
1.2.3 Wild-Type Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2017-2030)
2.2 Oncolytic Virus Immunotherapy Growth Trends by Region
2.2.1 Oncolytic Virus Immunotherapy Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Oncolytic Virus Immunotherapy Historic Market Size by Region (2017-2023)
2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2023-2030)
2.3 Oncolytic Virus Immunotherapy Market Dynamics
2.3.1 Oncolytic Virus Immunotherapy Industry Trends
2.3.2 Oncolytic Virus Immunotherapy Market Drivers
2.3.3 Oncolytic Virus Immunotherapy Market Challenges
2.3.4 Oncolytic Virus Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2017-2023)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2017-2023)
3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2022
3.5 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Immunotherapy Breakdown Data by Type
4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2017-2023)
4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2023-2030)
5 Oncolytic Virus Immunotherapy Breakdown Data by Application
5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2017-2023)
5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size (2017-2030)
6.2 North America Oncolytic Virus Immunotherapy Market Size by Country (2017-2023)
6.3 North America Oncolytic Virus Immunotherapy Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size (2017-2030)
7.2 Europe Oncolytic Virus Immunotherapy Market Size by Country (2017-2023)
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2017-2030)
8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Country (2017-2023)
8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2017-2030)
9.2 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2017-2023)
9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2017-2030)
10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2017-2023)
10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Oncolytic Virus Immunotherapy Introduction
11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.1.5 Merck Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.2.5 Amgen Recent Development
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Detail
11.3.2 TILT Biotherapeutics Business Overview
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.3.5 TILT Biotherapeutics Recent Development
11.4 Oncorus
11.4.1 Oncorus Company Detail
11.4.2 Oncorus Business Overview
11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.4.5 Oncorus Recent Development
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Detail
11.5.2 Sorrento Therapeutics Business Overview
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.5.5 Sorrento Therapeutics Recent Development
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Detail
11.6.2 Shanghai Sunway Biotech Business Overview
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2023)
11.6.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Engineering Oncolytic Viruses
Table 3. Key Players of Wild-Type Oncolytic Viruses
Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 6. Global Oncolytic Virus Immunotherapy Market Size by Region (2017-2023) & (US$ Million)
Table 7. Global Oncolytic Virus Immunotherapy Market Share by Region (2017-2023)
Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 9. Global Oncolytic Virus Immunotherapy Market Share by Region (2023-2030)
Table 10. Oncolytic Virus Immunotherapy Market Trends
Table 11. Oncolytic Virus Immunotherapy Market Drivers
Table 12. Oncolytic Virus Immunotherapy Market Challenges
Table 13. Oncolytic Virus Immunotherapy Market Restraints
Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2017-2023) & (US$ Million)
Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2017-2023)
Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2022)
Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2017-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
Table 21. Date of Enter into Oncolytic Virus Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2017-2023) & (US$ Million)
Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2017-2023)
Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2023-2030)
Table 27. Global Oncolytic Virus Immunotherapy Market Size by Application (2017-2023) & (US$ Million)
Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2017-2023)
Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2023-2030)
Table 31. North America Oncolytic Virus Immunotherapy Market Size by Country (2017-2023) & (US$ Million)
Table 32. North America Oncolytic Virus Immunotherapy Market Size by Country (2023-2030) & (US$ Million)
Table 33. Europe Oncolytic Virus Immunotherapy Market Size by Country (2017-2023) & (US$ Million)
Table 34. Europe Oncolytic Virus Immunotherapy Market Size by Country (2023-2030) & (US$ Million)
Table 35. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2017-2023) & (US$ Million)
Table 36. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2023-2030) & (US$ Million)
Table 37. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2017-2023) & (US$ Million)
Table 38. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2023-2030) & (US$ Million)
Table 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2017-2023) & (US$ Million)
Table 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2023-2030) & (US$ Million)
Table 41. Merck Company Detail
Table 42. Merck Business Overview
Table 43. Merck Oncolytic Virus Immunotherapy Product
Table 44. Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 45. Merck Recent Development
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Oncolytic Virus Immunotherapy Product
Table 49. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. TILT Biotherapeutics Company Detail
Table 52. TILT Biotherapeutics Business Overview
Table 53. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
Table 54. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 55. TILT Biotherapeutics Recent Development
Table 56. Oncorus Company Detail
Table 57. Oncorus Business Overview
Table 58. Oncorus Oncolytic Virus Immunotherapy Product
Table 59. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 60. Oncorus Recent Development
Table 61. Sorrento Therapeutics Company Detail
Table 62. Sorrento Therapeutics Business Overview
Table 63. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
Table 64. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 65. Sorrento Therapeutics Recent Development
Table 66. Shanghai Sunway Biotech Company Detail
Table 67. Shanghai Sunway Biotech Business Overview
Table 68. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
Table 69. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2023) & (US$ Million)
Table 70. Shanghai Sunway Biotech Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Immunotherapy Market Share by Type: 2022 VS 2030
Figure 2. Engineering Oncolytic Viruses Features
Figure 3. Wild-Type Oncolytic Viruses Features
Figure 4. Global Oncolytic Virus Immunotherapy Market Share by Application in 2022 & 2030
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Oncolytic Virus Immunotherapy Report Years Considered
Figure 9. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 10. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 11. Global Oncolytic Virus Immunotherapy Market Share by Region: 2022 VS 2030
Figure 12. Global Oncolytic Virus Immunotherapy Market Share by Players in 2022
Figure 13. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2022
Figure 15. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 16. North America Oncolytic Virus Immunotherapy Market Share by Country (2017-2030)
Figure 17. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 18. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 20. Europe Oncolytic Virus Immunotherapy Market Share by Country (2017-2030)
Figure 21. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 24. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. Nordic Countries Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2017-2030)
Figure 29. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 32. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2017-2030)
Figure 37. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2017-2030)
Figure 41. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 44. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 45. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 46. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 47. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 48. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Industry Market Size
